National Comprehensive Cancer Network

Educational Events & Programs

CONFERENCE DATES > Thursday, March 31 – Saturday, April 2, 2016REGISTER >

CONFERENCE LOCATION > The Diplomat • Hollywood, Florida

EARLY BIRD REGISTRATION > Expires Wednesday, February 17, 2016REGISTER >

2016 NURSING PROGRAM > Wednesday, March 30, 2016       REGISTER >
This educational event has reached maximum capacity. All registrants from this point on will be placed on a wait-list and will be contacted if a seat becomes available.

NCCN ACADEMY > Wednesday, March 30, 2016      ENROLL NOW >

Overview

The NCCN Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

The Annual Conference General Session begins on Thursday, March 31, 2016 at 8:00 AM and concludes on Saturday evening, April 2, 2016. This year's agenda includes more than 25 educational sessions featuring the latest advances in oncology care, plus interactive patient case studies & roundtable discussions. NCCN will also offer concurrent sessions so that attendees can customize their learning experience.

This conference (with the exception of the NCCN Roundtable Discussion - Emerging Issues in Oncology: Cancer Care in An Election Year) is approved for AMA PRA Category 1 Credit™ for physicians and is also certified for nurses, pharmacists, and other oncology professionals. NCCN will also seek approval for case manager and tumor registrar clock hours.

Roundtable Discussions*:

Palliative Care: Providing Comfort from a Patient and Provider Perspective
Thursday, March 31, 2016
This interactive discussion will feature a multidisciplinary team of providers plus a family member to address aspects of palliative care, hospice care, and best supportive care practices. The challenges of symptom management and end-of-life issues will also be discussed to determine where we are and where we need to be in standardizing care.

Moderator:

Thomas J. Smith, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

An NCCN Roundtable Discussion
Emerging Issues in Oncology: Cancer Care in an Election Year
Friday, April 1, 2016 

Moderators:

Kavita Patel, MD, MSHS
Nonresident Senior Fellow
Brookings Institution
Marc Samuels, JD, MPH
Founder & CEO
ADVI

This non-accredited roundtable discussion will address important issues facing various oncology stakeholders including access to, quality of, and appropriateness of care.

This roundtable is sponsored by AbbVie; Astellas/Medivation; Boehringer Ingelheim Pharmaceuticals, Inc.; BTG; ImpediMed; Karyopharm Therapeutics; Merck; Myriad Genetics, Inc.; and Takeda Oncology. This activity is supported by an educational donation provided by Amgen.


Agenda*:

Thursday, March 31, 2016

 7:00 - 8:00 AM

Breakfast, Exhibits, and General Poster Session I (Exhibition Hall)

 8:00 - 8:10 AM

Welcome and Opening Remarks
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

 8:15 - 9:30 AM

Palliative Care: Providing Comfort from a Patient and Provider Perspective

Moderator: 

Thomas J. Smith, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Panelists: 

Maria Dans, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Sophia Smith, PhD, MSW
Duke Cancer Institute

Carri Siedlik, APRN, ACHPN
Fred & Pamela Buffett Cancer Center

Additional Panelist TBD

 9:30 - 9:50 AM

Break, Exhibits, and General Poster Session I (Exhibition Hall)

 9:50 - 10:50 AM

Strategies for Management of Early Stage Breast Cancer
in Older Women
Sarah L. Blair, MD
UC San Diego Moores Cancer Center

Lee Schwartzberg, MD
The University of Tennessee Health Science Center

Management of Advanced Phase Chronic Myelogenous Leukemia
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

 10:50 - 11:00 AM

Break, Exhibits, and General Poster Session I (Exhibition Hall)

 11:00 AM -12:00 PM

Major Changes in Systemic Therapy for Advanced Melanoma
John A. Thompson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Evolving Uses of Androgen Deprivation Therapy (ADT) in
Prostate Cancer Management
James Mohler, MD
Roswell Park Cancer Institute

 12:00 - 1:15 PM

Lunch, Exhibits, and General Poster Session I (Exhibition Hall)

 1:15 - 2:15 PM

 

Role of Biosimilars
Pamela Becker, MD, PhD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Sexual Function in Cancer Survivors:
Updates to the NCCN Guidelines® for Survivorship
Michelle Melisko, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Joseph Narus, DNP, APRN, NP
Memorial Sloan Kettering Cancer Center

 2:15 - 2:25 PM

Break and Exhibits (Exhibition Hall)

 2:25 - 3:25 PM

The NCCN Value Initiative:
Using NCCN Evidence Blocks™ in Clinical Decisions
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center

Evolving Treatment Strategies for Cervical Cancer
Nadeem Abu-Rustum, MD
Memorial Sloan Kettering Cancer Center

 3:25 - 3:45 PM

Break and Exhibits (Exhibition Hall)

 3:45 - 4:45 PM

Selection of Optimal Treatment Strategies
in Metastatic Colorectal Cancer
Alan Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center

NCCN Guidelines® Update: Locoregional Treatment Approaches for Hepatocellular Carcinoma
Daniel T. Chang, MD
Stanford Cancer Institute

Anne Covey, MD
Memorial Sloan Kettering Cancer Center

 4:45 - 5:30 PM

Free Time

 5:30 - 7:30 PM

Welcome Reception (Exhibition Hall)

 

Friday, April 1, 2016

 7:00 - 8:00 AM

Breakfast, Exhibits, and General Poster Session II (Exhibition Hall)

 8:00 - 8:05 AM

Opening Remarks

 8:10 - 9:30 AM

An NCCN Roundtable Discussion
Emerging Issues in Oncology: Cancer Care in an Election Year

Moderators:

Kavita Patel, MD, MSHS
Nonresident Senior Fellow
Brookings Institution

Marc Samuels, JD, MPH
Founder & CEO
ADVI

Confirmed Panelists:

Lanhee J. Chen, PhD
David and Diane Steffy Research Fellow at the Hoover Institution

Scott Gottlieb, MD
American Enterprise Institute

Invited Panelists:

Chris Jennings
Founder and President
Jennings Policy Strategies, Inc.

This non-accredited roundtable discussion will address important issues facing various oncology stakeholders including access to, quality of, and appropriateness of care.

This roundtable is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; BTG; ImpediMed; Karyopharm Therapeutics; Myriad Genetics, Inc.; and Takeda Oncology. This activity is supported by an educational donation provided by Amgen.

 9:30 - 9:50 AM

Break, Exhibits, and General Poster Session II (Exhibition Hall)

 9:50 - 10:50 AM

Multigene Testing in Prostate Cancer Risk Stratification
Ashley Ross, MD, PhD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Emerging Paradigms in the Treatment of Localized Rectal Cancer
Christopher Willett, MD
Duke Cancer Institute

 10:50 - 11:00 AM

Break, Exhibits, and General Poster Session II (Exhibition Hall)

 11:00 AM -12:00 PM

NCCN Guidelines® Updates: Breast Cancer
William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center at Northwestern University

Kilian Salerno, MD
Roswell Park Cancer Institute

 12:00 - 1:15 PM

Lunch, Exhibits, and General Poster Session II (Exhibition Hall)

 1:15 - 2:15 PM

Understanding and Utilizing Patient Preferences in Cancer Treatment Decisions
Peter A. Ubel, MD
Duke Cancer Institute

 2:15 - 2:25 PM

Break and Exhibits (Exhibition Hall)

 2:25 - 3:25 PM

Updates on Diagnostic Criteria and Management of Multiple Myeloma
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute

Metastatic Gastroesophageal Cancers:
Current and Emerging Treatment Options
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center

 3:25 - 3:45 PM

Break and Exhibits (Exhibition Hall)

 3:45 - 4:45 PM

Venous Thromboembolism in Patients with Cancer:
Assessment of Risk and Safe Prophylaxis
John Fanikos, RPh, MBA
Dana-Farber Cancer Institute

Michael B. Streiff, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

New NCCN Guidelines® for Vulvar Cancer
Benjamin E. Greer, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Wui-Jin Koh, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

 

Saturday, April 2, 2016

 7:00 - 8:00 AM

Breakfast (Great Hall Foyer)

 8:00 - 8:05 AM

Opening Remarks

 8:10 - 9:25 AM

B-Cell Lymphomas: Optimizing Treatment with Small Molecule Inhibitors
John Byrd, MD
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

William Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

 9:30 - 10:45 AM

Management of EGFR-Mutation Positive Metastatic Non-Small Cell Lung Cancer
Leora Horn, MD, MSc
Vanderbilt-Ingram Cancer Center

Rogerio Lilenbaum, MD
Yale Cancer Center/Smilow Cancer Hospital

 10:45 - 11:00 AM

Break (Great Hall Foyer)

 11:00 - 12:00 PM

Controversies in Breast Cancer Screening Strategies
Therese Bevers, MD
The University of Texas MD Anderson Cancer Center

Kirsten Bibbins-Domingo, MD, PhD, MAS
University of California, San Francisco

Kevin Oeffinger, MD
Memorial Sloan Kettering Cancer Center

Speaker TBD
Institution TBD

Central Nervous System:
Notable Developments in the Management of
Primary and Recurrent Gliomas
Louis Burt Nabors, MD
University of Alabama at Birmingham Comprehensive Cancer Center

 12:00 - 12:45 PM

Lunch (Great Hall Foyer)

12:45 - 1:45 PM

Cancer Pain Management:
Strategies for Safe and Effective Opioid Prescribing
Judith Paice, PhD, RN, FAAN
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Diagnosis and Staging of Pancreatic Cancer:
The Role of Imaging
Mahmoud Al-Hawary, MD
University of Michigan Comprehensive Cancer Center

1:50 - 2:50 PM

Hereditary Breast and Ovarian Cancers: Risk Management Recommendations
Tuya Pal, MD
Moffitt Cancer Center

 2:50 - 3:00 PM

Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President/Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.


Intended Audience

This conference is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Accreditation Information

This conference is approved for AMA PRA Category 1 Credit™ for physicians and is also certified for nurses, pharmacists, and other oncology professionals. NCCN will also seek approval for case manager and tumor registrar clock hours.

Supporters

This conference is supported by educational grants from AstraZeneca; Celgene Corporation; Clovis Oncology; Genentech; Genomic Health, Inc.; Lilly; Novartis Oncology; Taiho Oncology; Takeda Oncology; and TESARO. Supported by independent educational grants from Astellas and Medivation, Inc.; and Boehringer Ingelheim Pharmaceuticals, Inc.
(As of January 19, 2016)

Fees

Reserve your seat by Wednesday, February 17, 2016 to receive the Early Bird Registration rate. Learn more.

Registration fee discounts are available to NCCN Member Institution employees! 
As a benefit of membership, NCCN extends a registration fee discount to staff employed at NCCN Member Institutions. Learn more.

Accommodations

NCCN has a limited number of rooms reserved at The Diplomat. Only registered conference attendees will be eligible for a room in an NCCN room block. Housing reservations should be submitted no later than Wednesday, February 17, 2016. Early booking is strongly encouraged. Learn more

Airline Travel

NCCN is proud to partner with Delta Air Lines and United Airlines to offer attendees of the NCCN 21st Annual Conference an opportunity to earn discounted airfares. Please see detailed reservations and ticketing information available here for each carrier.

Avis Rental Car

Avis is the preferred rental car supplier for the NCCN 21st Annual Conference. Learn more.

Travel Agency

Travel Leaders is the official travel agency for NCCN. William Lopez, NCCN’s exclusive agent, will make a reservation on your behalf. Learn more.


Exhibitor Information

Organizations who are interested in exhibits or sponsorships are encouraged to send an e-mail to exhibits@nccn.org


Future NCCN Annual Conference Dates:

  • March 23 – 25, 2017- NEW LOCATION!
    NCCN 22nd Annual Conference: Advancing the Standard of Cancer Care™
    Rosen Shingle Creek, Orlando, FL
    Pre-conference programs take place on March 22, 2017

  • March 22 – 24, 2018
    NCCN 23rd Annual Conference: Advancing the Standard of Cancer Care™
    Rosen Shingle Creek, Orlando, FL
    Pre-conference programs take place on March 21, 2018

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.